Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical GW870086X in adults with moderate or severe atopic dermatitis
2010-022280-35Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW870086 in atopic dermatitis (AD) (4 arms), sponsored by GSK. Primary endpoint: Change from baseline in Three Item Severity score at Day 22. Started Sep 2010; status: completed.
02
Drugs
GW870086
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2010-022280-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022280-35.